[go: up one dir, main page]

NO20013971D0 - Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre - Google Patents

Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre

Info

Publication number
NO20013971D0
NO20013971D0 NO20013971A NO20013971A NO20013971D0 NO 20013971 D0 NO20013971 D0 NO 20013971D0 NO 20013971 A NO20013971 A NO 20013971A NO 20013971 A NO20013971 A NO 20013971A NO 20013971 D0 NO20013971 D0 NO 20013971D0
Authority
NO
Norway
Prior art keywords
preparation
propyloctanoic acid
acid
propyloctanoic
octanoic acid
Prior art date
Application number
NO20013971A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013971L (no
Inventor
Norikazu Toda
Kaoru Yamaguchi
Youichi Iguchi
Original Assignee
Tokyo Kasei Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Kasei Kogyo Co Ltd filed Critical Tokyo Kasei Kogyo Co Ltd
Publication of NO20013971L publication Critical patent/NO20013971L/no
Publication of NO20013971D0 publication Critical patent/NO20013971D0/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/42—Platinum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/18—Carbon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
NO20013971A 1999-02-18 2001-08-15 Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre NO20013971D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3975899 1999-02-18
PCT/JP2000/000900 WO2000048982A1 (en) 1999-02-18 2000-02-17 Process for the preparation of (2r)-2-propyloctanoic acid

Publications (2)

Publication Number Publication Date
NO20013971L NO20013971L (no) 2001-08-15
NO20013971D0 true NO20013971D0 (no) 2001-08-15

Family

ID=12561862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013971A NO20013971D0 (no) 1999-02-18 2001-08-15 Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre

Country Status (19)

Country Link
US (1) US6608221B1 (zh)
EP (3) EP1714956A1 (zh)
JP (2) JP4752989B2 (zh)
KR (1) KR100666423B1 (zh)
CN (4) CN1907938A (zh)
AT (1) ATE359256T1 (zh)
AU (1) AU776927B2 (zh)
BR (1) BR0008261A (zh)
CA (1) CA2364308C (zh)
DE (1) DE60034316T2 (zh)
ES (1) ES2283287T3 (zh)
HU (1) HUP0200358A3 (zh)
MX (1) MXPA01008241A (zh)
NO (1) NO20013971D0 (zh)
NZ (1) NZ513569A (zh)
RU (1) RU2297406C2 (zh)
TW (1) TWI268921B (zh)
WO (1) WO2000048982A1 (zh)
ZA (1) ZA200106500B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
JP4178405B2 (ja) 2001-07-18 2008-11-12 小野薬品工業株式会社 脳虚血疾患治療剤
JP2005298334A (ja) * 2001-12-19 2005-10-27 Ono Pharmaceut Co Ltd 新規な中間体化合物およびそれを用いる化合物の製造方法
NZ546231A (en) 2003-10-03 2009-09-25 Ono Pharmaceutical Co Drug containing (2R)-2-propyloctanoic acid as the active ingredient
US7928143B2 (en) * 2003-10-03 2011-04-19 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
EP1669066A4 (en) * 2003-10-03 2009-04-29 Ono Pharmaceutical Co TRANSFUSION PREPARATION CONTAINING (2R) -2-PROPYLOCTANOIC ACID AS ACTIVE INGREDIENT
US7820715B2 (en) 2004-04-28 2010-10-26 Ono Pharmaceutical Co., Ltd. Crystal comprising (2R)-2-propyloctanoic acid and amine
WO2006055404A2 (en) * 2004-11-16 2006-05-26 Merck & Co., Inc. Compounds for targeting mechanisms implicated in the progression of stroke
JPWO2006075596A1 (ja) * 2005-01-13 2008-06-12 株式会社クラレ ２−アリルカルボン酸化合物の製造方法
EP1859795A4 (en) 2005-03-15 2008-06-04 Ono Pharmaceutical Co THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
WO2007000970A1 (ja) 2005-06-27 2007-01-04 Ono Pharmaceutical Co., Ltd. 疼痛治療剤
EP1938814A4 (en) 2005-10-18 2009-06-03 Ono Pharmaceutical Co PHARMACEUTICAL PRODUCT FOR PROTECTING MOTOR NERVE IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
EP1974727A4 (en) 2005-12-22 2009-12-09 Ono Pharmaceutical Co THERAPEUTIC AGENT AGAINST ACUTE CEREBRALINE INFARC
US20090118542A1 (en) * 2006-02-16 2009-05-07 Shigeya Yamazaki Process for Production of Optically Active Carboxlic Acid Compound
US20090325862A1 (en) * 2006-05-04 2009-12-31 Christian Steinkuhler Histone Deacetylase Inhibitors for the Treatment of Neurodegeneration
CN102417445B (zh) * 2011-11-05 2013-11-13 中国科学院山西煤炭化学研究所 一种由马来酸合成丁二酸的方法
CN102675166B (zh) * 2012-05-11 2014-03-26 山东齐都药业有限公司 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法
CN102786407B (zh) * 2012-08-15 2014-04-16 湖北大学 一种制备(2r)-2-丙基辛酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2317019A1 (de) 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
JPH0672123B2 (ja) * 1986-08-21 1994-09-14 セントラル硝子株式会社 トリフルオロメチル基を有するシクロヘキサンカルボン酸の製造方法
JP2868183B2 (ja) * 1988-02-29 1999-03-10 株式式社三和化学研究所 光学活性を有する４−オキソ−１−ベンゾピラン−２−カルボン酸誘導体の製法、その合成用中間体並びに該中間体の製法
US5202474A (en) * 1989-06-22 1993-04-13 Monsanto Company Asymmetric catalytic hydrogenation of α-arylpropenoic acids
TW248552B (zh) 1993-06-01 1995-06-01 Onoda Yakuhin Kogyo Kk
JP3032447B2 (ja) * 1995-04-24 2000-04-17 小野薬品工業株式会社 光学活性な２−プロピルオクタン酸の製造方法
JP3084345B2 (ja) * 1995-04-26 2000-09-04 小野薬品工業株式会社 光学活性な２−プロピルオクタン酸の製造方法
TW509672B (en) * 1998-05-12 2002-11-11 Ono Pharmaceutical Co Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
US7820715B2 (en) * 2004-04-28 2010-10-26 Ono Pharmaceutical Co., Ltd. Crystal comprising (2R)-2-propyloctanoic acid and amine

Also Published As

Publication number Publication date
EP1714956A1 (en) 2006-10-25
CN1636957A (zh) 2005-07-13
KR20010102161A (ko) 2001-11-15
CN1341091A (zh) 2002-03-20
HUP0200358A3 (en) 2003-03-28
MXPA01008241A (es) 2002-08-30
ATE359256T1 (de) 2007-05-15
AU776927B2 (en) 2004-09-23
CN1907938A (zh) 2007-02-07
DE60034316D1 (de) 2007-05-24
WO2000048982A1 (en) 2000-08-24
NO20013971L (no) 2001-08-15
TWI268921B (en) 2006-12-21
CA2364308C (en) 2010-02-02
JP5343925B2 (ja) 2013-11-13
CN100430364C (zh) 2008-11-05
RU2001125501A (ru) 2004-02-20
AU2573000A (en) 2000-09-04
CA2364308A1 (en) 2000-08-24
CN1183082C (zh) 2005-01-05
CN101100422A (zh) 2008-01-09
BR0008261A (pt) 2002-01-15
NZ513569A (en) 2003-01-31
HUP0200358A2 (hu) 2002-05-29
JP2010248198A (ja) 2010-11-04
DE60034316T2 (de) 2008-01-03
US6608221B1 (en) 2003-08-19
EP1153910A4 (en) 2002-08-07
ES2283287T3 (es) 2007-11-01
JP4752989B2 (ja) 2011-08-17
EP1153910A1 (en) 2001-11-14
EP1153910B1 (en) 2007-04-11
KR100666423B1 (ko) 2007-01-11
EP1721882A1 (en) 2006-11-15
ZA200106500B (en) 2003-02-07
RU2297406C2 (ru) 2007-04-20

Similar Documents

Publication Publication Date Title
NO20013971D0 (no) Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre
ES2149800T3 (es) Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermediarios en la preparacion de taxanos.
NO20006606L (no) Fremgangsmåte for fremstilling av en vandig monoester peroksykarboksylsyreopplösning, opplösningen som kan oppnås ved denne fremgangsmåten og dens anvendelse som desinfeksjonsmiddel
CA2019939A1 (en) Hydrophobic nucleic acid probe
NO875347L (no) Fremgangsmaate for fremstilling av organiske karbonater ved omestring.
ITTO920532A0 (it) Procedimento per la preparazione di delta lattoni saturi per bioidro-genazione dei corrispondenti composti insaturi naturali mediante microrganismi.
PT98518A (pt) Processo para a preparacao de 4-amino-delta-4-esteroides com accao inibidora da5alfa-redutase
ATE126191T1 (de) Verfahren zur herstellung p,p'-biphenol.
DE69926994D1 (de) Substanzen, welche apoptose einleiten können
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
AU581185B2 (en) Process for the racemization of optically active aminoacids
EP0344791A3 (en) Process for the enzymatic resolution of the optical isomers of racemic ester derivatives of 3-mercapto-2-alkyl-propionic acid
ES2058224T3 (es) Procedimiento para la hidrolisis enzimatica de compuestos alfa-aminoadipinil-monoaminicos.
HUT48593A (en) Process for producing asymmetric 1,4-dihydropyridinecarboxylic acid esters
FR2708929B1 (fr) Procédé de préparation d'esters d'acide cyclopropane-1,1-dicarboxylique.
IT8821757A0 (it) Processo per la preparazione di prodotti di addizione di ossidi alchidici su composti contenenti idrogeni mobili.
FR2696450B1 (fr) Procédé d'isomérisation de l'acide pentène-2-oïque en acides pentène-3-oïque et pentène-4-oïque par catalyse acide.
ES2089327T3 (es) Procedimiento e intermediarios para la preparacion de un agente antivirico que contiene un grupo ciclobutilo.
ATE76868T1 (de) Verfahren zur herstellung von 1,2-disulfonverbindungen.
IT1190436B (it) Processo stereoselettivo per la preparazione di composti carbonilici alfa,beta-disostituiti otticamente attivi
FR2696451B1 (fr) Procédé d'isomérisation de l'acide pentène-2-oïque en acides pentène-3-oïque et pentène-4-oïque par catalyse basique.
FR2696449B1 (fr) Procédé d'isomérisation de lactones en acides penténoïques par catalyse basique.
PT87064A (pt) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts
ATE85972T1 (de) Verfahren zur herstellung von methylhydrochinon.
DE59409775D1 (de) Enzymatische Racematspaltung asymmetrischer Alkinole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application